Niagen Bioscience, Inc. — All Filings
956 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
144
3
3/A
4
4/A
424B3
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
NT 10-Q
POS AM
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | FORM 3 | 0001628280-24-046708 | Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | 10-Q | 0001628280-24-044540 | Oct 31, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001628280-24-044541 | Oct 31, 2024 | — |
| 4 | FORM 4 | 0001628280-24-043462 | Oct 23, 2024 | Oct 21, 2024 |
| 3 | FORM 3 | 0001628280-24-043461 | Oct 23, 2024 | Oct 21, 2024 |
| 8-K | 8-K | 0001628280-24-042724 | Oct 11, 2024 | Oct 8, 2024 |
| 8-K | 8-K | 0001628280-24-040982 | Sep 20, 2024 | Sep 19, 2024 |
| 4 | FORM 4 | 0001628280-24-038470 | Aug 26, 2024 | Aug 23, 2024 |
| 144 | — | 0001974494-24-000081 | Aug 23, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-204002 | Aug 21, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-204003 | Aug 21, 2024 | — |
| 4 | 4 | 0000950170-24-099382 | Aug 21, 2024 | Sep 30, 2022 |
| 4 | 4 | 0000950170-24-099383 | Aug 21, 2024 | Sep 6, 2023 |
| 8-K | 8-K | 0001628280-24-035593 | Aug 7, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-035591 | Aug 7, 2024 | Jun 30, 2024 |
| 3 | FORM 3 | 0001628280-24-033180 | Jul 26, 2024 | Jul 16, 2024 |
| 8-K | 8-K | 0001628280-24-031955 | Jul 16, 2024 | — |
| 8-K | 8-K | 0001628280-24-029936 | Jun 25, 2024 | Jun 19, 2024 |
| 4 | FORM 4 | 0001628280-24-029652 | Jun 24, 2024 | Jun 20, 2024 |
| 4 | FORM 4 | 0001628280-24-029653 | Jun 24, 2024 | Jun 20, 2024 |
| 4 | FORM 4 | 0001628280-24-029650 | Jun 24, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0001628280-24-029643 | Jun 24, 2024 | Jun 20, 2024 |
| 4 | FORM 4 | 0001628280-24-029647 | Jun 24, 2024 | Jun 20, 2024 |
| 4 | FORM 4 | 0001628280-24-029648 | Jun 24, 2024 | Jun 20, 2024 |
| 4 | FORM 4 | 0001628280-24-029395 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | FORM 4 | 0001628280-24-029397 | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0001628280-24-021648 | May 8, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-021645 | May 8, 2024 | Mar 31, 2024 |
| ARS | ARS | 0001628280-24-018148 | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | DEFA14A | 0001628280-24-018142 | Apr 25, 2024 | — |
| DEF 14A | DEF 14A | 0001628280-24-018138 | Apr 25, 2024 | — |
| 10-K | 10-K | 0001628280-24-009380 | Mar 6, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001628280-24-009383 | Mar 6, 2024 | — |
| 4 | FORM 4 | 0001628280-24-006725 | Feb 23, 2024 | Feb 22, 2024 |
| 4 | FORM 4 | 0001628280-24-006724 | Feb 23, 2024 | Feb 22, 2024 |
| 8-K | 8-K | 0001628280-23-041428 | Dec 13, 2023 | Dec 8, 2023 |
| 4 | FORM 4 | 0001628280-23-040625 | Dec 4, 2023 | Dec 1, 2023 |
| 8-K | 8-K | 0001628280-23-037816 | Nov 8, 2023 | — |
| 10-Q | 10-Q | 0001628280-23-037809 | Nov 8, 2023 | Sep 30, 2023 |
| SC 13D/A | SC 13D/A | 0001193125-23-230038 | Sep 7, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-23-018667 | Sep 7, 2023 | Sep 6, 2023 |
| 4 | FORM 4 | 0001628280-23-029599 | Aug 15, 2023 | Aug 12, 2023 |
| 10-Q | 10-Q | 0001628280-23-028551 | Aug 9, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001628280-23-028555 | Aug 9, 2023 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001174947-23-000897 | Jul 6, 2023 | — |
| EFFECT | — | 9999999995-23-001983 | Jul 5, 2023 | — |
| CORRESP | — | 0001174947-23-000894 | Jun 30, 2023 | — |
| UPLOAD | — | 0000000000-23-006856 | Jun 27, 2023 | — |
| S-3 | REGISTRATION STATEMENT | 0001174947-23-000873 | Jun 22, 2023 | — |
| S-8 | REGISTRATION STATEMENT | 0001174947-23-000875 | Jun 22, 2023 | — |